Member Info for DanRey

I thought came across well. Some interesting figures and product information.

Strange drop. I can sell my holding but can’t buy the same amount. Someone wants the shares.

Didn’t expect that. Wish it had been nearer to 3.

I was hoping the interview was planned in relation to news following an RNS. I don’t think the new medical officer would warrant that so hopefully more to come.

Mr India I sold out so can’t comment.

No answer revealed at this time to what the concern of the FDA is. So still we wait.

Maybe we will get both. Here’s hoping.

Just took some more. Exciting hopefully must be worth another punt.

All the little knocks add up. I thought with hemo taking so long to apply with FDA input the process would be smoother and to then suddenly be pulled up at the last hurdle causes reasonable doubt which obviously knocks confidence hence back to 1.50. I remember being told how wonderful the mint funding was and then a slow walk down in share price leading to a placement at 1.50. Vlad will have to provide a lot of information to install confidence. Just my frustrated opinion.

Steve I believe and correct me if I am wrong that OCTP are further on in their trials than hemo as they have been granted permission to carry out trials.

Very disappointed. Thought we had finally turned the corner. Feels like Mint all over again. A delay it may be but will have dented confidence again. I always use to say Vlad the scientist and not the business man. If we are going to get through the next month I pray the science is sound.

When I initially saw the headline I thought it was us. Hopefully one day soon.

The sells are buys. 2.32 to buy. Only showing as a sell as below the mid price.

Think we will move up again soon. Purely based on the fact that I can comfortably sell but not easily buy.

Seems a low mid cap for a company that has moved to clinical trials?

Up we go again!

Dhub tick up soon!

There are equally as large sells.

I thought with yesterdays rise we may get an RNS this morning.

Rise must surely be down to news very soon I would have thought